The Prediction Value of the Systemic Inflammation Score for Oral Cavity Squamous Cell Carcinoma

Objectives This study aimed to investigate the potential prognostic role of the oral cancer systemic inflammation score (SIS) based on serum albumin levels and the lymphocyte-to-monocyte ratio in patients with oral squamous cell carcinoma (OSCC) after treatment. Study Design A retrospective cohort study. Setting Tertiary care center. Subjects and Methods The study involved 613 patients who were treated for OSCC between September 2005 and December 2014. The association of the oral cancer SIS with various clinicopathological features was investigated. A nomogram based on different clinicopathological features and SIS was established to predict prognosis. Results Higher SIS was significantly associated with older age (P = .0013), advanced tumor status (P < .0001), tumor depth (P < .0001), advanced overall pathologic stage (P < .0001), and extranodal extension (P = .0045), as well as the presence of perineural invasion (P = .0341). Higher SIS, older age, overall stage, and extranodal extension were demonstrated to be independent prognostic indicators for shorter overall survival (P < .0001). A nomogram comprising SIS, TNM stage, and the degree of cell differentiation, as well as perineural invasion and extranodal extension, was developed to predict the prognosis of these patients. The c-index of the nomogram model based on TNM staging only was 0.688 and could be increased to 0.752 if SIS and several other clinicopathological parameters were incorporated. Conclusions Higher SIS is associated with many poor prognosticators, and the nomogram that was established and based on the incorporation of SIS might strengthen the prediction of prognosis in patients with OSCC.

[1]  Ying Sun,et al.  Socioeconomic factors and survival in patients with non‐metastatic head and neck squamous cell carcinoma , 2017, Cancer science.

[2]  Weijia Xie,et al.  Association of Systemic Inflammation Score With Atrial Fibrillation: A Case-Control Study With Propensity Score Matching. , 2017, Heart, lung & circulation.

[3]  Shulin Chen,et al.  A Novel Inflammation-Based Stage (I Stage) Predicts Overall Survival of Patients with Nasopharyngeal Carcinoma , 2016, International journal of molecular sciences.

[4]  Moyi Sun,et al.  Nomograms predicting long-term overall survival and cancer-specific survival in head and neck squamous cell carcinoma patients , 2016, Oncotarget.

[5]  Fei-yun Zheng,et al.  Cervical cancer systemic inflammation score: a novel predictor of prognosis , 2016, Oncotarget.

[6]  Jianqing Xu,et al.  Systemic inflammation score predicts postoperative prognosis of patients with clear-cell renal cell carcinoma , 2015, British Journal of Cancer.

[7]  J. Waldron,et al.  Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status , 2015, Cancer.

[8]  D. McMillan,et al.  Systemic inflammatory response and survival in patients undergoing curative resection of oral squamous cell carcinoma. , 2015, The British journal of oral & maxillofacial surgery.

[9]  K. Pummer,et al.  Low preoperative lymphocyte-monocyte ratio (LMR) represents a potentially poor prognostic factor in nonmetastatic clear cell renal cell carcinoma. , 2014, Urologic oncology.

[10]  Jie-wen Peng,et al.  Increased lymphocyte to monocyte ratio is associated with better prognosis in patients with newly diagnosed metastatic nasopharyngeal carcinoma receiving chemotherapy , 2014, Tumor Biology.

[11]  A. Gerger,et al.  The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas , 2014, International journal of cancer.

[12]  J. Coffey,et al.  Ratios derived from an array of standard haematological indices predict the oncological outcome in colon cancer , 2014, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[13]  R. Metgud,et al.  Serum and salivary levels of albumin as diagnostic tools for oral pre-malignancy and oral malignancy , 2014, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

[14]  Kai-Ping Chang,et al.  Serum levels of chemokine (C-X-C motif) ligand 9 (CXCL9) are associated with tumor progression and treatment outcome in patients with oral cavity squamous cell carcinoma. , 2013, Oral oncology.

[15]  V. Gebski,et al.  Markers of systemic inflammation predict survival in patients with advanced renal cell cancer , 2013, British Journal of Cancer.

[16]  Kai-Ping Chang,et al.  Pretreatment Interleukin-6 Serum Levels Are Associated with Patient Survival for Oral Cavity Squamous Cell Carcinoma , 2013, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[17]  T. Yen,et al.  The number of pathologically positive lymph nodes and pathological tumor depth predicts prognosis in patients with poorly differentiated squamous cell carcinoma of the oral cavity. , 2011, International journal of radiation oncology, biology, physics.

[18]  D. Talwar,et al.  A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. , 2011, European journal of cancer.

[19]  R. Lambert,et al.  Epidemiology of cancer from the oral cavity and oropharynx , 2011, European journal of gastroenterology & hepatology.

[20]  T. Yen,et al.  Prognostic cytokine markers in peripheral blood for oral cavity squamous cell carcinoma identified by multiplexed immunobead-based profiling. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[21]  Jeffrey W. Pollard,et al.  Macrophage Diversity Enhances Tumor Progression and Metastasis , 2010, Cell.

[22]  D. McMillan Systemic inflammation, nutritional status and survival in patients with cancer , 2009, Current opinion in clinical nutrition and metabolic care.

[23]  S. Warnakulasuriya Global epidemiology of oral and oropharyngeal cancer. , 2009, Oral oncology.

[24]  P. Allavena,et al.  Cancer-related inflammation , 2008, Nature.

[25]  B. Aggarwal,et al.  TNF: a master switch for inflammation to cancer. , 2008, Frontiers in bioscience : a journal and virtual library.

[26]  R. Schreiber,et al.  The immunobiology of cancer immunosurveillance and immunoediting. , 2004, Immunity.

[27]  D. Kyriakou,et al.  Levels of Serum Cytokines and Acute Phase Proteins in Patients With Essential and Cancer‐Related Thrombocytosis , 2003, American journal of clinical oncology.

[28]  C. McArdle,et al.  Albumin Concentrations Are Primarily Determined by the Body Cell Mass and the Systemic Inflammatory Response in Cancer Patients With Weight Loss , 2001, Nutrition and cancer.

[29]  N. Soni,et al.  Serum albumin: touchstone or totem? , 1998, Anaesthesia.

[30]  N. Sakamoto,et al.  Cancer-Specific Mortality and Competing Mortality in Patients with Head and Neck Squamous Cell Carcinoma: A Competing Risk Analysis , 2014, Annals of Surgical Oncology.

[31]  Magdalena Kowalewska,et al.  Systemic inflammation as a confounding factor in cancer biomarker discovery and validation , 2010, Nature Reviews Cancer.

[32]  D. Wilson,et al.  The epidemiology of mouth cancer: a review of global incidence. , 2000, Oral diseases.